Apexigen, Inc.
APGN · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $10,627 | $11,764 | $13 | $55,307 |
| - Cash | $9,369 | $12,730 | $14,802 | $12,708 |
| + Debt | $0 | $0 | $106 | $210 |
| Enterprise Value | $1,258 | -$966 | -$14,683 | $42,809 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6,158 | -$6,199 | -$13,568 | -$8,799 |
| % Margin | – | – | – | – |
| Net Income | -$6,047 | -$5,890 | -$6,538 | -$8,185 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | -0.24 | -330.41 | -0.4 |
| % Growth | 0% | 99.9% | -82,502.5% | – |
| Operating Cash Flow | -$3,001 | -$6,762 | -$3,053 | $387,799 |
| Capital Expenditures | $0 | $0 | $0 | -$14 |
| Free Cash Flow | -$3,001 | -$6,762 | -$3,053 | $387,785 |